Cefadroxil
Product Images NDC 70934-081

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefadroxil (NDC 70934-081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

70934 081 14 Master Bottle Label Approval Rev A 10 20

70934 081 14 Master Bottle Label Approval Rev A 10 20
Label for Cefadroxil Capsules USP 500 mg by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The package contains 14 capsules. The label includes storage instructions, dosage directions to see the package insert, and safety information such as keeping out of reach of children and storage at controlled room temperature.*
FDA Label Image

Molecular Structure (Cefadroxilcapsules Figure 01)

Molecular Structure (Cefadroxilcapsules Figure 01)
Chemical structure of Cefadroxil as shown in the image, depicting its molecular framework including a beta-lactam ring, a side chain with a phenyl group, and attached functional groups including a carboxyl group and a water molecule (hydrate).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.